MedTrace Logo

Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s)

NCT03369756 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2020-12-08

Study results available
· View outcomes & findings →

Summary

This study evaluates the use of Prontosan® Wound Irrigation Solution and Prontosan® Wound Gel in the treatment of chronic leg wounds in adults. All participants will use Prontosan and report their personal observations regarding Quality of Life.

Conditions

  • Wound of Lower Leg (Physical Finding)

Interventions

DEVICE

Prontosan Wound Irrigation Solution and Prontosan Wound Gel

Wound cleansing using Prontosan solution and gel

Sponsors & Collaborators

  • B. Braun Medical Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-20
Primary Completion
2019-09-25
Completion
2019-09-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369756 on ClinicalTrials.gov